134 related articles for article (PubMed ID: 692233)
1. [Myasthenia gravis (3). Corticosteroid therapy of myasthenia gravis].
Matell G; Osterman PO
Lakartidningen; 1978 Oct; 75(41):3667-9. PubMed ID: 692233
[No Abstract] [Full Text] [Related]
2. [Corticosteroid therapy in myasthenia gravis: preliminary considerations on the long-term treatment with prednisone].
Cornelio F; Caraceni T; Negri S
Riv Neurobiol; 1974; 20(14):78-86. PubMed ID: 4220136
[No Abstract] [Full Text] [Related]
3. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients.
Pascuzzi RM; Coslett HB; Johns TR
Ann Neurol; 1984 Mar; 15(3):291-8. PubMed ID: 6721451
[TBL] [Abstract][Full Text] [Related]
4. Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment.
Seybold ME; Drachman DB
N Engl J Med; 1974 Jan; 290(2):81-4. PubMed ID: 4808454
[No Abstract] [Full Text] [Related]
5. Letter: Prednisone schedule for myasthenia gravis.
McQuillen MP
N Engl J Med; 1974 Mar; 290(11):631-2. PubMed ID: 4812507
[No Abstract] [Full Text] [Related]
6. [Predictive factors of the response to treatment of myasthenia gravis with prednisone].
Pradas J; Illa I
Neurologia; 1990 Jan; 5(1):11-3. PubMed ID: 2361025
[TBL] [Abstract][Full Text] [Related]
7. Myasthenia gravis: generalized vs ocular, and children vs adults.
Wang HS
Arch Neurol; 2003 Oct; 60(10):1491; author reply 1492. PubMed ID: 14568824
[No Abstract] [Full Text] [Related]
8. Long-term corticosteroid treatment of myasthenia gravis.
Johns TR
Ann N Y Acad Sci; 1987; 505():568-83. PubMed ID: 3479938
[No Abstract] [Full Text] [Related]
9. [The effect of prolonged treatment with prednisone on myasthenia gravis].
Melamed E; Reches A; Silberberg R; Soffer D
Harefuah; 1975 Jan; 88(2):65-7. PubMed ID: 1112555
[No Abstract] [Full Text] [Related]
10. Myasthenia gravis and scleroderma.
Bhalla R; Swedler WI; Lazarevic MB; Ajmani HS; Skosey JL
J Rheumatol; 1993 Aug; 20(8):1409-10. PubMed ID: 8230029
[TBL] [Abstract][Full Text] [Related]
11. Trends in therapy: prednisone for myasthenia gravis.
Patten BM
Tex Med; 1976 Dec; 72(12):54-5. PubMed ID: 1006553
[No Abstract] [Full Text] [Related]
12. [Large dose of prednisone in the treatment of the oculomuscular type of myasthenia gravis].
Wang DC
Zhonghua Yan Ke Za Zhi; 1984 Jul; 20(4):245-7. PubMed ID: 6439528
[No Abstract] [Full Text] [Related]
13. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Cervera C; Armengol M
Neurology; 2005 May; 64(9):1641-3. PubMed ID: 15883336
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroid-induced mediastinal widening in myasthenia gravis.
Strother CM
Arch Neurol; 1975 Oct; 32(10):702-3. PubMed ID: 1180735
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment of myasthenia gravis with alternate-day prednisone. Report on 15 patients.
Pinelli P; Tonali P; Scoppetta C
Eur Neurol; 1974; 12(3):129-41. PubMed ID: 4426321
[No Abstract] [Full Text] [Related]
16. Clinical predictors of steroid-induced exacerbation in myasthenia gravis.
Bae JS; Go SM; Kim BJ
J Clin Neurosci; 2006 Dec; 13(10):1006-10. PubMed ID: 17074487
[TBL] [Abstract][Full Text] [Related]
17. Is myasthenia gravis an autoimmune disease?
Chriss JW
Tex Med; 1973 May; 69(5):72-4. PubMed ID: 4702315
[No Abstract] [Full Text] [Related]
18. Plasmapheresis as a guide for azathioprine therapy in prednisone-resistant myasthenia gravis.
Rodnitzky RL; Bosch EP
Muscle Nerve; 1981; 4(6):529-30. PubMed ID: 7311992
[No Abstract] [Full Text] [Related]
19. Long-term administration of corticosteroids in myasthenia gravis.
Mann JD; Johns TR; Campa JF
Neurology; 1976 Aug; 26(8):729-40. PubMed ID: 821005
[TBL] [Abstract][Full Text] [Related]
20. Steroid therapy of myasthenia gravis.
Vijayan N; Dreyfus PM
West J Med; 1975 Aug; 123(2):130-1. PubMed ID: 170745
[No Abstract] [Full Text] [Related]
[Next] [New Search]
